add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Ranbaxy Launches Generic Valtrex in usWall Street Journal - - 7 hours ago "Ranbaxy Pharmaceuticals has introduced valacyclovir hydrochloride, 500 milligram and 1 gram tablets, having previously been granted US FDA approval for ... Ranbaxy takes on GSK's Valtrex in US Times of India Ranbaxy set for Rs 1000 cr boost from Valtrex clone Daily News & Analysis Astellas Pharma: Dropped US Lawsuit Against FDA Drug DecisionWall Street Journal - Nov 25, 2009 CORRECT: (11/25) Teva Files 2nd Citizen's Petition To Block Generic CopaxoneWall Street Journal - - 28 minutes ago Drug makers can ask the FDA to use special criteria when considering approval of generic copies of branded drugs, citing health or safety reasons. ... Natco to dare Teva on Copaxone Daily News & Analysis Indian pharma co criticises Israeli firm over citizen petition Trading Markets (press release) Teva trying to delay ANDA approval, says Natco mydigitalfc.com Greater risks seen with certain imaging agents: FDAReuters - - Nov 25, 2009 WASHINGTON (Reuters) - A US Food and Drug Administration review found the risk of a serious skin disorder is greater with MRI imaging ... Intelence Receives Full FDA ApprovalAIDSmeds.com HIV/AIDS Treatment News - Nov 25, 2009 The US Food and Drug Administration (FDA) has granted full approval to the non-nucleoside reverse transcriptase inhibitor (NNRTI) Intelence (etravirine). ... FDA grants full approval to J&J's HIV drug The Associated Press A Mostly Meaningless FDA ApprovalMotley Fool - - 1 hour ago The HIV drug was approved under an accelerated approval process, in which the FDA accepts a minimal amount of data and expects the drugmaker to complete ... FDA Extends Comment Period on AcrylamideFood Safety News - - 7 hours ago The US Food and Drug Administration (FDA) is extending the comment period for the agency's notice requesting comments, ... Human Genome Sciences Submits Biologics License Application to FDA for ZALBIN™WELT ONLINE - Nov 25, 2009 A BLA has been submitted for ZALBIN to the FDA in the United States, and Novartis targets submission of marketing authorization applications under the brand ... Market Report -- In Play (HGSI) MSN Money Human Genome Sciences seeks approval for Zalbin The Associated Press FDA approves prescription pain patch based on herbal remedy capsaicinExaminer.com - Nov 19, 2009 The US Food and Drug Administration (FDA) approved the first prescription strength capsaicin product: Qutenza, a prescription pain patch designed to reduce ... NeurogesX Wins FDA Approval For Pain Treatment Qutenza Wall Street Journal Qutenza Approved for Post-Shingles Nerve Pain U.S. News & World Report FDA Addresses Drug Ads In Online Social MediaRedOrbit - Nov 13, 2009 During a two-day public hearing hosted by the US Food and Drug Administration, pharmaceutical companies, Internet firms and nonprofit organizations came out ... Experts Tell FDA Not To Expect Too Much From Drug Ads On Web Wall Street Journal FDA to Discuss Social Media Ad Regulation by Biotech Industry Digitaltrends.com | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
